MTLS: Materialise NV
About
Materialise NV engages in the provision of additive manufacturing software and 3D printing services. It operates through the following segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The Materialise Software segment offers proprietary software worldwide through programs and platforms that enable companies to set up reliable and sustainable 3D printing production. The Materialise Medical segment includes medical software solutions, medical devices and other related products and services. The Materialise Manufacturing segment provides 3D printed services to industrial and commercial customers. The company was founded by Wilfried Vancraen and Hilde Ingelaere on June 28, 1990 and is headquartered in Leuven, Belgium.
Current Value
$6.821 Year Return
Current Value
$6.821 Year Return
Key Details
Market Cap
$399.00M
P/E Ratio
36.77
1Y Stock Return
3.76%
1Y Revenue Growth
6.71%
Dividend Yield
0.00%
Price to Book
1.4
Strategies that include MTLS
Stock's related to MTLS
Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| MTCH | 40.40% | $7.61B | -4.87% | 0.00% |
| MCFT | 39.45% | $344.65M | -0.29% | 0.00% |
| APPN | 38.52% | $2.72B | -0.51% | 0.00% |
| TSLA | 37.69% | $1.11T | +43.45% | 0.00% |
| FVRR | 37.12% | $1.07B | +33.94% | 0.00% |
| PEGA | 35.61% | $7.36B | +65.88% | 0.14% |
| AMSF | 34.23% | $1.11B | +22.66% | 2.52% |
| MGTX | 32.74% | $467.36M | +9.12% | 0.00% |
| AVXL | 32.64% | $698.71M | +22.62% | 0.00% |
| NTB | 32.50% | - | - | 4.69% |
| CPS | 32.33% | $244.48M | -24.67% | 0.00% |
| FARO | 32.18% | $486.17M | +40.51% | 0.00% |
| ATOM | 31.90% | $160.01M | -20.00% | 0.00% |
| DDD | 31.85% | $402.06M | -35.13% | 0.00% |
| ORGO | 31.52% | $540.91M | +59.38% | 0.00% |
| AOMR | 31.45% | $220.30M | -5.07% | 17.13% |
| RDWR | 31.41% | $960.27M | +53.82% | 0.00% |
| NVEC | 31.40% | $364.49M | +7.38% | 5.30% |
| DENN | 30.46% | $321.32M | -35.73% | 0.00% |
| NEWT | 30.33% | $364.85M | +5.72% | 5.42% |
Uncorrelated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| API | 0.01% | $299.01M | +33.12% | 0.00% |
| NVO | 0.03% | $342.62B | -0.15% | 1.40% |
| MAX | 0.04% | $681.47M | +32.02% | 0.00% |
| MRK | -0.07% | $244.21B | -5.55% | 3.18% |
| CORZ | -0.08% | $4.60B | +3,201.26% | 0.00% |
| ACRS | 0.16% | $327.87M | +415.67% | 0.00% |
| CRIS | -0.19% | $32.09M | -55.52% | 0.00% |
| AXON | -0.21% | $46.53B | +167.14% | 0.00% |
| WTTR | -0.26% | $1.45B | +92.87% | 1.78% |
| PSEC | 0.27% | - | - | 15.48% |
| CNC | -0.27% | $29.19B | -21.56% | 0.00% |
| CB | -0.28% | $114.43B | +26.00% | 1.24% |
| CHCT | -0.29% | $527.85M | -29.47% | 9.98% |
| PRT | 0.30% | $48.72M | -16.56% | 10.33% |
| CLX | 0.36% | $20.81B | +20.66% | 2.88% |
| VHC | 0.45% | $19.06M | -38.36% | 0.00% |
| KMB | -0.47% | $45.22B | +11.57% | 3.58% |
| RNR | -0.53% | $13.74B | +23.09% | 0.58% |
| BMY | -0.53% | $118.10B | +20.11% | 4.09% |
| SNDL | 0.58% | $525.69M | +33.78% | 0.00% |
Inversely Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| CHD | -17.86% | $27.18B | +19.50% | 1.03% |
| FCN | -17.85% | $7.10B | -10.74% | 0.00% |
| OCX | -17.75% | $42.93M | -36.09% | 0.00% |
| K | -16.01% | $27.77B | +52.50% | 2.79% |
| CYD | -14.19% | $364.46M | -2.94% | 4.26% |
| MCK | -14.01% | $78.15B | +35.51% | 0.42% |
| PRPO | -12.08% | $9.10M | -13.65% | 0.00% |
| NEUE | -12.08% | $40.93M | -34.13% | 0.00% |
| ICLR | -11.35% | $16.15B | -27.84% | 0.00% |
| MRNS | -10.81% | $16.97M | -94.82% | 0.00% |
| LMT | -10.70% | $126.40B | +18.99% | 2.36% |
| NOC | -10.69% | $71.54B | +4.23% | 1.60% |
| CPB | -10.49% | $12.96B | +7.08% | 3.40% |
| CME | -10.43% | $82.76B | +9.21% | 1.98% |
| GIS | -10.37% | $34.85B | -2.91% | 3.78% |
| PG | -9.79% | $402.15B | +14.14% | 2.33% |
| ROL | -9.72% | $23.98B | +23.53% | 1.25% |
| NNE | -9.66% | $833.66M | +531.50% | 0.00% |
| FCNCA | -9.54% | $31.02B | +54.47% | 0.30% |
| CL | -9.43% | $76.48B | +22.25% | 2.12% |
ETF's related to MTLS
News
Yahoo
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...
SeekingAlpha
Materialise: Strong Q3 Results Despite Ongoing Market Headwinds
Yahoo
Materialise NV's ( NASDAQ:MTLS ) strong earnings report was rewarded with a positive stock price move. Our analysis...
Yahoo
Materialise NV ( NASDAQ:MTLS ) investors will be delighted, with the company turning in some strong numbers with its...
Yahoo
Materialise NV (MTLS) reports a 14% revenue increase, with the Medical segment leading growth and strategic advancements in software partnerships.
Yahoo
Materialise (MTLS) has released an update. Materialise NV reported a 14.2% increase in total revenue for Q3 2024, reaching 68,652 kEUR, with notable growth in their Medical segment. Despite a decline in net profit compared to the previous year, the company achieved an 89% rise in Adjusted EBIT, indicating strong operational performance. Materialise continues to invest in future growth, maintaining confidence in meeting its full-year revenue and EBIT guidance. For further insights into MTLS stock
Disclaimer
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.